P1089: brentuximab vedotin, nivolumab, doxorubicin, and dacarbazine (an+ad) for advanced stage classic hodgkin lymphoma: preliminary safety and efficacy results from the phase 2 study (sgn35 027 part b)
HemaSphere（2022）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要